Carina Ortler

Gene editing and synthetically accessible inhibitors reveal role for TPC2 in HCC cell proliferation and tumor growth.

S. Zahler, A. Vollmar, Cheng-Chang Chen, 2021, Cell chemical biology.

Metabolic implication of tigecycline as an efficacious second‐line treatment for sorafenib‐resistant hepatocellular carcinoma

A. Vollmar, H. Zischka, A. Gerbes, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.